Mymetics Corp (MYMX)

[Work Harder]

How could we see Results from Phase1/2 later this year?

Next steps

Mymetics is currently evaluating possible the further development of a malaria vaccine in collaboration with

PATH-MVI and LMIV.

In parallel, Mymetics is in collaboration with the

Swiss Tropical and Public Health Institute

and researchers at

Oxford University

to add two important antigens for a possible malaria vaccine candidate,

the RH5

and

the CyRPA peptides

and has received access to EU supported laboratories under the

Transvac2

program to execute the development of the tetra-valent malaria vaccine candidate

and test this in

pre-clinical studies in 2019.

https://www.sec.gov/Archives/edgar/data/927761/000165495419003503/mymx_10q.htm

Yet we have been through Phase 1